Description

Nucynta (Tapentadol) 100mg

Clinical research has not shown conversion ratios for conversion from other opioids.Nucynta (Tapentadol) 100mg

Begin with tapentadol (50 mg PO every 12 hours.
It is preferable to underestimate the 24-hour oral tapentadol dosage and offer rescue medication (e.g., immediate-release opioid) rather than overestimate the 24-hour PO tapentadol requirements, which could result in an unpleasant reaction due to an overdose.
While useful tables of opioid equivalents are widely available, the strength of opioid medicines and opioid formulations varies from patient to patient.
Close monitoring and repeated titration are required until pain management on the new opioid is stable.
After converting, keep an eye out for signs of opioid withdrawal as well as signs of oversedation/toxicity.

• Nucynta (Tapentadol) 100mg
  • Titration to appropriate analgesia should be done in 50 mg increments, no more than twice daily every three days.
    Patients experiencing breakthrough pain may need to alter their dosage or use an immediate-release analgesic rescue drug.
    If the pain persists after the dose is adjusted, try to identify the source of the pain before increasing the dosage.
    Tapentadol is used to treat both acute (after an injury or surgery) and chronic musculoskeletal pain. When continuous opioid medication is required, it is also used to relieve the discomfort of diabetic neuropathy. Tapentadol extended-release formulations are not advised for acute pain management.
    Tapentadol is classified as Pregnancy Category C. Tapentadol has not been subjected to adequate or well-controlled human research.